Skip to main content

Table 3 Demographic characteristics of participants completing the baseline evaluation, by condition

From: Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation

  Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis Psoriasis Other a Total
Participants, n (% of total) 191 (55.5%) 43 (12.5%) 44 (12.8%) 35 (10.2%) 31 (9.0%) 344 (100%)
   Patient, n (%) 189 (99.0%) 43 (100.0%) 41 (93.2%) 33 (94.3%) 25 (80.6%) 331 (96.2%)
   Carer, n (%) 2 (1.0%) 0 (0.0%) 2 (4.5%) 1 (2.9%) 1 (3.2%) 6 (1.7%)
   Parent, n (%) 0 (0.0%) 0 (0.0%) 1 (2.3%) 1 (2.9%) 5 (16.1%) 7 (2.0%)
Sex       
   N [N missing] 189 [2] 43 [0] 41 [3] 33 [2] 17 [14] 323 [21]
   Male, n (%) 55 (29.1%) 32 (74.4%) 13 (31.7%) 15 (45.5%) 7 (41.2%) 122 (37.8%)
   Female, n (%) 134 (70.9%) 11 (25.6%) 28 (68.3%) 18 (54.5%) 10 (58.8%) 201 (62.2%)
Age       
   N [N missing] 189 [2] 43 [0] 41 [3] 33 [2] 17 [14] 323 [21]
   Mean (SD) 56.0 (12.5) 49.2 (12.3) 50.5 (9.5) 49.8 (11.0) 42.1 (13.4) 53.1 (12.6)
   Range 20.0-79.0 27.0-71.0 34.0-68.0 27.0-82.0 13.0- 68.0 13.0-82.0
  1. a Includes patients with juvenile idiopathic arthritis (n = 9, 2.6%), patients responding other or not sure of condition (n = 10, 2.9%) and patients with condition missing (n = 12, 3.5%) to the question 'What condition do you have that is being treated with Enbrel?'